Meridian Bioscience Return on Equity:
25.23% for Dec. 31, 2012Meridian Bioscience Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 25.23% |
| Dec. 31, 2012 | 25.17% |
| Sept. 30, 2012 | 23.81% |
| June 30, 2012 | 22.63% |
| March 31, 2012 | 21.47% |
| Dec. 31, 2011 | 19.89% |
| Sept. 30, 2011 | 19.50% |
| June 30, 2011 | 18.52% |
| March 31, 2011 | 18.20% |
| Dec. 31, 2010 | 17.20% |
| Sept. 30, 2010 | 19.25% |
| June 30, 2010 | 21.94% |
| March 31, 2010 | 23.63% |
| Dec. 31, 2009 | 24.83% |
| Sept. 30, 2009 | 24.64% |
| June 30, 2009 | 24.19% |
| March 31, 2009 | 24.12% |
| Dec. 31, 2008 | 24.74% |
| Sept. 30, 2008 | 24.99% |
| June 30, 2008 | 24.77% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
VIVO Return on Equity Benchmarks
| Companies | |
|---|---|
| Abaxis | 16.24% |
| Trinity Biotech | 10.77% |
| SurModics | 9.33% |
VIVO Return on Equity Rankings
| Overall |
93rd percentile 474 of 7590 |
| Sector |
94th percentile 36 of 651 in Healthcare |
| Industry |
91st percentile 5 of 61 in Diagnostics & Research |
VIVO Return on Equity Range, Past 5 Years
| Minimum | 17.20% | Dec 2010 |
| Maximum | 25.23% | Mar 2013 |
| Average | 22.44% |
